GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease
Lewy pathology affects the gastrointestinal tract in Parkinson's disease (PD) and recent reports suggest a link between the disorder and gut inflammation. In this study, we investigated enteric neuroprotection and macrophage immunomodulation by 17β-estradiol (E2) and the G protein-coupled estro...
Main Authors: | Mélissa Côté, Mélanie Bourque, Andrée-Anne Poirier, Benoit Aubé, Marc Morissette, Thérèse Di Paolo, Denis Soulet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996115001916 |
Similar Items
-
17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
by: Wei Fu, et al.
Published: (2020-01-01) -
Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson’s disease
by: Andrée-Anne Poirier, et al.
Published: (2022-09-01) -
Decreased Levels of G Protein-Coupled Estrogen Receptor in Bipolar Patients
by: Nurinnisa Öztürk, et al.
Published: (2023-08-01) -
Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
by: Qingming Ding, et al.
Published: (2022-10-01) -
The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
by: Christophe Mallet, et al.
Published: (2021-03-01)